Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sympathetic Neural Patterns in Obesity-associated Hypertension
NCT04838678Phase 1Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2021
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of neuropeptide Y (1-36) (4 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Blood flow measured by doppler ultrasound at Day 1 and Muscle sympathetic nervous system activity at Day 1. Started Jul 2021; status: recruiting.
02
Drugs
neuropeptide Y (1-36)
Beyond the preview
Go deeper on NCT04838678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838678.